Concepedia

CT Dang

CD

1

Publications

36

Citations

1

H-Index

2013

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

CT Dang is an author at Dana-Farber Cancer Institute specializing in cancer research, immunology, and cancer therapeutics.

Top concepts

Publications per year

2013–2013

1

Publications

1

Abstract S1-04: A phase II study of adjuvant paclitaxel (T) and trastuzumab (H) (APT trial) for node-negative, HER2-positive breast cancer (BC)

SM Tolaney, WT Barry, CT Dang et al. · Cancer Research · 2013 · 36 citations

, , +12

Rows per page

1–1 of 1